Effect of Carotid Corrected Flow Time Guided Fluid Management on Post-Induction Hypotension in Elderly Patients

Effect of Carotid Corrected Flow Time (FTc)-Guided Fluid Management on Post-Induction Hypotension in Elderly Patients Undergoing General Anesthesia

This study aimed to investigate the effect of carotid corrected flow time (FTc)-guided fluid management on post-induction hypotension in elderly patients undergoing general anesthesia.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Yiwu, Zhejiang, China, 322000
        • The Fourth Affiliated Hospital, Zhejiang University School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elderly patients aged ≥65 years scheduled for elective non-cardiac surgery under general anesthesia, ASA physical status I-III. Patients with emergency surgery, preoperative unstable hemodynamics, severe cardiovascular disease, pre-existing hypotension, or inability to obtain written informed consent will be excluded. Consecutive eligible patients will be enrolled in this single-center prospective observational study.

Description

Inclusion Criteria:

  • > 1. Obtain the informed consent form; > 2. Patients undergoing elective surgery under general anesthesia; > 3. American Society of Anesthesiologists (ASA) physical status classification I-III; > 4. Aged 65-80 years; > 5. Patients voluntarily participate in the study and sign the informed consent form.

Exclusion Criteria:

  • 1. Patients with sudden and life-threatening changes in preoperative vital signs; 2. History of neck surgery or trauma; 3. History of severe peripheral arterial disease or atherosclerosis; 4. BMI > 30 kg/m² or < 15 kg/m²; 5. History of cardiomyopathy or valvular heart disease; 6. Left ventricular ejection fraction (LVEF) < 50%; 7. Patients with an implanted pacemaker or implantable cardioverter-defibrillator (ICD); 8. Right ventricular dysfunction; 9. Chronic obstructive pulmonary disease (COPD); 10. Patients with secondary hypertension; 11. Patients with unclear ultrasound measurements, sustained blood pressure > 180/110 mmHg, temporary withdrawal, or unexpected difficult airway; 12. Patient refusal.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Observation cohort

All enrolled elderly patients undergoing non-cardiac surgery under general ansethesia.No investigational intervention will be performed.Anesthesia management follows routine clinical practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of post-induction hypotension
Time Frame: Within 5 minutes after anesthesia induction

The incidence of post-induction hypotension, defined as SBP reduction >30% from baseline, or MAP reduction >20% from baseline, or SBP<90 mmHg together with MAP<60 mmHg within 5 minutes after anesthesia induction. Baseline blood pressure refers to stable blood pressure measured before induction.

Within 5 minutes after anesthesia induction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: TianLun Zhu, The Fourth Affiliated Hospital, Zhejiang University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

December 30, 2027

Study Registration Dates

First Submitted

November 15, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KY-2025-198

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

ndividual participant data will not be shared publicly due to patient privacy protection and institutional data management regulations. Aggregated study results may be available upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe